NPI Details
Andrew S Friedman, MD is a physical medicine rehabilitation in Seattle, WA with 34 years of experience. The provider is physical medicine and rehabilitation, also referred to as rehabilitation medicine, is the medical specialty concerned with diagnosing, evaluating, and treating patients with physical disabilities. These disabilities may arise from conditions affecting the musculoskeletal system such as neck and back pain, sports injuries, or other painful conditions affecting the limbs, such as carpal tunnel syndrome. Alternatively, the disabilities may result from neurological trauma or disease such as spinal cord injury, head injury or stroke. A physician certified in physical medicine and rehabilitation is often called a physiatrist. The primary goal of the physiatrist is to achieve maximal restoration of physical, psychological, social and vocational function through comprehensive rehabilitation. Pain management is often an important part of the role of the physiatrist. For diagnosis and evaluation, a physiatrist may include the techniques of electromyography to supplement the standard history, physical, x-ray and laboratory examinations. The physiatrist has expertise in the appropriate use of therapeutic exercise, prosthetics (artificial limbs), orthotics and mechanical and electrical devices. Andrew S Friedman, MD NPI is 1013936343. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: UNIVERSITY OF MICHIGAN MEDICAL SCHOOL
Graduation Year:1991
The provider's business location address is:
1100 9TH AVE
SEATTLE, WA
ZIP 98101-756
Phone: (206) 223-6999
Fax: (206) 625-7278
The NPI 1013936343 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg (HCPCS:Q5103)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
- Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
- Nerve conduction, 7-8 studies (HCPCS:95910)
- Needle measurement of electrical activity in arm or leg muscles, complete study (HCPCS:95886)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
- New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
- Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
- Needle measurement of electrical activity in arm or leg muscles, limited study (HCPCS:95885)
- Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
- Nerve conduction, 7-8 studies (HCPCS:95910)
- Injection of additional new drug or substance into vein (HCPCS:96375)
- Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
- Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
- Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle (HCPCS:95874)
- New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
- Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity (HCPCS:64643)
- New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
- Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity (HCPCS:64644)
- Nerve conduction, 11-12 studies (HCPCS:95912)
- Aspiration and/or injection of fluid from large joint (HCPCS:20610)
- Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
The enumeration date for this NPI number is 7/18/2006 and was last updated on 6/23/2009.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 208100000X | Physical Medicine & Rehabilitation | | MD00031061 | WASHINGTON | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 206033 | OTHER | WASHINGTON | LABOR AND INDUSTRIES |
| 2 | G17672 | MEDICARE UPIN | | |
| 3 | MD6103 | OTHER | WASHINGTON | ALASKA MEDICAID |
| 4 | FR5117 | OTHER | WASHINGTON | BLUE SHIELD |
| 5 | 0039622 | OTHER | WASHINGTON | LABOR & INDUSTRY |
| 6 | 805441900 | MEDICAID | IDAHO | |
| 7 | 805441900 | OTHER | WASHINGTON | IDAHO MEDICAID |
| 8 | 8181455 | MEDICAID | WASHINGTON | |
| 9 | MD6103 | MEDICAID | ALASKA | |
| 10 | 000182311 | MEDICARE PIN | WASHINGTON | |
| 11 | G17672 | MEDICARE UPIN | WASHINGTON | |
| 12 | 990005755 | OTHER | | RAILROAD MEDICARE |
| 13 | US0862704 | OTHER | WASHINGTON | AETNA/USHC SPECIALIST |
